Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Braz. j. biol ; Braz. j. biol;78(4): 619-624, Nov. 2018. tab, graf
Article in English | LILACS | ID: biblio-951603

ABSTRACT

Abstract Leaves and roots of Acanthospermum australe (Asteraceae) have been used in Brazilian folk medicine for the treatment of various ailments including diarrhea, skin diseases, blennorrhagia, dyspepsia, parasitic worms and malaria. The aim of study was to characterize the chemical profiles of the aqueous and hydroalcoholic extracts of leaves and roots of A. australe, and to evaluate their antimicrobial activities against diarrhea-inducing bacteria (Enterococcus faecalis, Shigella dysenteriae and Yersinia enterocolitica), as well as their cytotoxic properties. Aqueous leaf extracts were obtained by infusion, while aqueous root extracts were obtained by decoction. The hydroalcoholic leaf and root extracts were prepared by maceration in 90% ethanol for 3 days. Antimicrobial activity was assessed using standard techniques and cytotoxicity was evaluated using Chinese hamster ovary cells CHO-K1. Chemical analysis revealed the presence of tannins, flavonoids, saponins and phenolic compounds in the extracts. Although root extracts were not effective against E. faecalis, leaf extracts at concentrations of 20 mg/mL exhibited bactericidal activities against this microorganism. The hydroalcoholic root extract was unique in presenting a bactericidal effect against S. dysenteriae. None of the extracts showed bacteriostatic or bactericidal activities against Y. enterocolitica. The results presented herein demonstrate that the Gram-positive E. faecalis and the Gram-negative S. dysenteriae were susceptible to A. australe extracts, although bacteriostatic/bactericidal activities were only observed at concentrations considered too high for clinical application. Our results support the ethnopharmacological use of A. australe in the treatment of gastrointestinal disorders, particularly diarrhea caused by infectious bacteria, although further studies are required to determine the anti-diarrhea effects and the toxicities of the extracts in vivo.


Resumo Folhas e raízes de Acanthospermum australe (Asteraceae) têm sido usadas na medicina popular brasileira para o tratamento de várias doenças, incluindo diarreia, doenças de pele, blenorragia, dispepsia, vermes parasitas e malária. O objetivo deste estudo foi caracterizar os perfis químicos dos extratos aquosos e hidroalcoólicos das raízes e folhas de A. australe, e avaliar as suas atividades antimicrobianas contra as bactérias indutoras de diarreia (Enterococcus faecalis, Shigella dysenteriae e Yersinia enterocolitica), bem como sua citotoxicidade. Os extratos aquosos de folhas foram obtidos por infusão, enquanto que os extratos aquosos de raízes foram obtidos por decocção. Os extratos hidroalcoólicos de folhas e raízes foram preparados por maceração em etanol a 90% durante 3 dias. A atividade antimicrobiana foi avaliada utilizando técnicas padrão e a citotoxicidade foi avaliada utilizando células de ovário de hamster chinês CHO-K1. A análise química revelou a presença de taninos, flavonóides, saponinas e compostos fenólicos nos extratos. Apesar de extratos de raiz não foram eficazes contra E. faecalis, extratos de folhas em concentrações de 20 mg/mL apresentaram atividades bactericidas contra este microrganismo. O extrato hidroalcoólico de raiz foi o único a apresentar um efeito bactericida contra S. dysenteriae. Nenhum dos extratos apresentaram atividades bacteriostáticas ou bactericidas contra Y. enterocolitica. Os resultados apresentados demonstram que a bactéria Gram-positiva E. faecalis e a Gram-negativa S. dysenteriae foram suscetíveis aos extratos de A. australe, embora as atividades bacteriostáticos/bactericidas tenham sido apenas observados em concentrações consideradas elevadas para aplicação clínica. Os nossos resultados apoiam a utilização de etnofarmacológica de A. australe no tratamento de perturbações gastrointestinais, especialmente diarreia causadas por bactérias infecciosas, embora sejam necessários mais estudos para determinar os efeitos anti-diarreia e as toxicidades dos extratos in vivo.


Subject(s)
Shigella dysenteriae/drug effects , Yersinia enterocolitica/drug effects , Plant Extracts/pharmacology , Enterococcus faecalis/drug effects , Asteraceae/chemistry , Diarrhea/microbiology , Anti-Bacterial Agents/pharmacology , Plants, Medicinal , Brazil , Plant Extracts/chemistry , Microbial Sensitivity Tests , Toxicity Tests , Plant Roots/chemistry , Plant Leaves/chemistry , Medicine, Traditional
2.
An Acad Bras Cienc ; 90(1 Suppl 2): 1043-1057, 2018.
Article in English | MEDLINE | ID: mdl-29694500

ABSTRACT

Annulated thienopyrimidine derivatives attracted big interest of the scientific community due to their broad spectrum of biological activities among which are the inhibition of phosphodiesterase, antiproliferative and antimicrobial activities. As a continuation of our studies on the synthesis and biological activity of fused thieno[3,2-d]pyrimidine derivatives, the goal of this paper is the synthesis and study of the properties of compounds containing different heterocycles such as fused thieno[2,3-b]pyridine and tetrazolo[1,5-c]pyrimidine in the same molecule. Thus, starting from the ethyl 1-amino-5-isopropyl-8,8-dimethyl-8,9-dihydro-6H-pyrano[4,3-d]thieno[2,3-b]pyridine-2-carboxylate 1, efficient methods for obtaining new 8-amino-5-isopropyl-2,2-dimethyl-10-(methylthio)-1,4-dihydro-2H-pyrano[4'',3'':4',5']pyrido[3',2':4,5]thieno[3,2-d]pyrimidines 6 and thieno[2,3-e]tetrazolo[1,5-c]pyrimidine 8 are described. The spectroscopic results showed that compound 8 in the solid state is exclusively in the tetrazolo tautomeric form, while in solution an azide-tetrazole equilibrium is present 8A/T. The possible antimicrobial activity of newly synthesized compounds against some gram-positive and gram-negative bacilli strains has been evaluated. The biological tests evidenced that some of them showed promising antimicrobial activity. Two compounds showed similar activity to the one of the used reference drug. The study of structure-activity relationships revealed that the activity of a compound depends mostly on the nature of substituent R1R2. According to the predicted docking studies our compounds could be DnaG inhibitors.


Subject(s)
Amides/chemical synthesis , Anti-Bacterial Agents/chemical synthesis , Escherichia coli/drug effects , Pyrans/chemical synthesis , Shigella dysenteriae/drug effects , Staphylococcus aureus/drug effects , Amides/pharmacology , Anti-Bacterial Agents/pharmacology , Disk Diffusion Antimicrobial Tests , Pyrans/pharmacology , Structure-Activity Relationship
3.
Braz J Biol ; 78(4): 619-624, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29319752

ABSTRACT

Leaves and roots of Acanthospermum australe (Asteraceae) have been used in Brazilian folk medicine for the treatment of various ailments including diarrhea, skin diseases, blennorrhagia, dyspepsia, parasitic worms and malaria. The aim of study was to characterize the chemical profiles of the aqueous and hydroalcoholic extracts of leaves and roots of A. australe, and to evaluate their antimicrobial activities against diarrhea-inducing bacteria (Enterococcus faecalis, Shigella dysenteriae and Yersinia enterocolitica), as well as their cytotoxic properties. Aqueous leaf extracts were obtained by infusion, while aqueous root extracts were obtained by decoction. The hydroalcoholic leaf and root extracts were prepared by maceration in 90% ethanol for 3 days. Antimicrobial activity was assessed using standard techniques and cytotoxicity was evaluated using Chinese hamster ovary cells CHO-K1. Chemical analysis revealed the presence of tannins, flavonoids, saponins and phenolic compounds in the extracts. Although root extracts were not effective against E. faecalis, leaf extracts at concentrations of 20 mg/mL exhibited bactericidal activities against this microorganism. The hydroalcoholic root extract was unique in presenting a bactericidal effect against S. dysenteriae. None of the extracts showed bacteriostatic or bactericidal activities against Y. enterocolitica. The results presented herein demonstrate that the Gram-positive E. faecalis and the Gram-negative S. dysenteriae were susceptible to A. australe extracts, although bacteriostatic/bactericidal activities were only observed at concentrations considered too high for clinical application. Our results support the ethnopharmacological use of A. australe in the treatment of gastrointestinal disorders, particularly diarrhea caused by infectious bacteria, although further studies are required to determine the anti-diarrhea effects and the toxicities of the extracts in vivo.


Subject(s)
Anti-Bacterial Agents/pharmacology , Asteraceae/chemistry , Diarrhea/microbiology , Enterococcus faecalis/drug effects , Plant Extracts/pharmacology , Shigella dysenteriae/drug effects , Yersinia enterocolitica/drug effects , Brazil , Medicine, Traditional , Microbial Sensitivity Tests , Plant Extracts/chemistry , Plant Leaves/chemistry , Plant Roots/chemistry , Plants, Medicinal , Toxicity Tests
5.
BMC Microbiol ; 4: 18, 2004 Apr 28.
Article in English | MEDLINE | ID: mdl-15115555

ABSTRACT

BACKGROUND: Shigella is the etiological agent of shigellosis, a disease responsible for more than 500,000 deaths of children per year, in developing countries. These pathogens colonize the intestinal colon, invade, spreading to the other enterocytes. Breastfeeding plays a very important role in protecting infants from intestinal infections. Amongst milk compounds, glycosylated proteins prevent the adhesion of many enteropathogens in vitro. The aim of this work was to determine the effect of human milk proteins on the colonization potential of Shigella dysenteriae, S. flexneri and S. sonnei. To fulfill this purpose, pooled milk samples from five donors, were fractionated by gel filtration and affinity chromatography. Using tissue culture, the milk fractions obtained were tested in Shigella adhesion and invasion assays. RESULTS: Our revealed showed that both adhesion and invasion of Shigella species were inhibited by low concentration of secretory immunoglobulin A, lactoferrin and free secretory component. This work also showed that, these proteins bind to superficial and whole-cell Shigella proteins. CONCLUSIONS: Our findings suggest that human milk may act inhibiting adhesion and, consequently, invasion of Shigella, thereafter preventing shigellosis in infants.


Subject(s)
Bacterial Adhesion/drug effects , Milk Proteins/pharmacology , Shigella dysenteriae/pathogenicity , Shigella flexneri/pathogenicity , Shigella sonnei/pathogenicity , Antibodies, Bacterial/pharmacology , Bacterial Proteins/immunology , Bacterial Proteins/metabolism , Child , HeLa Cells , Humans , Immunoglobulin A, Secretory/immunology , Lactoferrin/metabolism , Periodic Acid/pharmacology , Shigella dysenteriae/drug effects , Shigella dysenteriae/isolation & purification , Shigella flexneri/drug effects , Shigella flexneri/isolation & purification , Shigella sonnei/drug effects , Shigella sonnei/isolation & purification
7.
J Infect Dis ; 163(2): 406-9, 1991 Feb.
Article in English | MEDLINE | ID: mdl-1671055

ABSTRACT

During 1988 the number of Shigella dysenteriae type 1 infections reported in the United States increased fivefold. To determine if recent isolates from Mexico were related to those that caused epidemics of dysentery worldwide, Southern hybridization analysis was done with Shiga toxin and ribosomal RNA gene probes. Western hemisphere and Eastern Hemisphere strains differed by the size of a single EcoRI fragment carrying the Shiga toxin genes. Three ribosomal DNA (rDNA) patterns were observed, which correlated with the strain's continental origin for 81 of 83 isolates tested. Together the Shiga toxin and rDNA probe results indicated that recent Mexican isolates were chromosomally similar to earlier Central American isolates and distinct from Asian and African strains. This suggests there has been no significant exchange of organisms between continents in recent decades and that the 1988 outbreak in Mexico was caused by strains present in Central America since at least 1962.


Subject(s)
Dysentery, Bacillary/epidemiology , Shigella dysenteriae/classification , Africa/epidemiology , Anti-Bacterial Agents/pharmacology , Asia/epidemiology , Bacterial Toxins/genetics , Central America/epidemiology , DNA, Ribosomal/analysis , Disease Outbreaks , Dysentery, Bacillary/microbiology , Humans , Mexico/epidemiology , Plasmids , Polymorphism, Restriction Fragment Length , RNA, Ribosomal/analysis , Shiga Toxins , Shigella dysenteriae/drug effects , Shigella dysenteriae/genetics , Travel , United States/epidemiology
8.
In. Anon. Memorias del V curso internacional: "Avances en enfermedad diarreíca y desequilibrio hidroelectrolitico". s.l, Mexico. Secretaría de Salud, 1991. p.81-9.
Monography in Spanish | LILACS | ID: lil-118499

ABSTRACT

El descubrimiento de los antibióticos y su aplicación clínica ha permitido el tratamiento y control de padecimientos infecciosos. Por otra parte, se ha descubierto que algunas enterobacterias desarrollan resistencia a las drogas antimocrobianas causada, principalmente por la presencia de elementos extracromosómicos denominados plasmidos. De entre estos microorganismos se han estudiado la salmonella y shigella con la finalidad de determinar las características de las mismas, los antibióticos a que se resisten y con cuales pueden ser tratados los padecimientos provocados por las mismas. La presencia de epidemias y las endemias en regiones de México así como en otras regiones del mundo, y consecuentemente el alto índice de morbilidad han inducido a los especialistas a investigar los procesos infecciosos provocados por shigella y la salmonella, se ha logrado establecer una clasificación de las mismas así como la sintomatología que producen las mismas. Para establecer un tratamiento determinado, se aisló al agente infeccioso, se le sometió a estudios para poder establecer a que drogas eran resistentes y a cuales no. De este modo se ha podido descrubir que algunos tipos de estas bacterias son resistentes, por ejemplo, al clorafenicol, la tetraciclina, la estreptomicina y a la ampicilina, en tanto que otras son suceptibles a los mismos, así mismo se ha observado que la región guarda cierta relación con el desarrollo de la resistencia


Subject(s)
Diarrhea/diagnosis , Salmonella typhi/analysis , Salmonella/drug effects , Shigella dysenteriae/analysis , Shigella flexneri/analysis , Diarrhea/parasitology , Mexico , Salmonella typhi/drug effects , Salmonella/analysis , Shigella dysenteriae/drug effects
9.
Lancet ; 2(8662): 543-5, 1989 Sep 02.
Article in English | MEDLINE | ID: mdl-2570242

ABSTRACT

In 1988, the number of Shigella dysenteriae type 1 (Sd1) infections reported in the USA increased five-fold over the annual mean from the previous decade. 44 (94%) of 47 interviewed patients reported recent travel to Mexico; 33 (75%) of these had been tourists to the Yucatan peninsula. 27 patients who had travelled to Mexico were admitted to hospital, of whom 2 had a haemolytic uraemic syndrome; none died. The antimicrobial resistance pattern and plasmid profile of the Yucatan strain were similar to those of the 1969-72 pandemic strain. Antimicrobial resistances and plasmid profiles were different in sporadic Western hemisphere strains. This is the first outbreak of Sd1 among US tourists and it is the largest known outbreak in the Western hemisphere since the early 1970s. The dominant Sd1 strain is similar to that which caused the catastrophic 1969-72 pandemic. Surveillance and control measures have been instituted in the Yucatan peninsula.


Subject(s)
Disease Outbreaks , Dysentery, Bacillary/epidemiology , Travel , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Child , Child, Preschool , Dysentery, Bacillary/complications , Dysentery, Bacillary/etiology , Dysentery, Bacillary/prevention & control , Dysentery, Bacillary/therapy , Female , Humans , Male , Mexico , Middle Aged , Plasmids/drug effects , Retrospective Studies , Shigella dysenteriae/classification , Shigella dysenteriae/drug effects , Shigella dysenteriae/isolation & purification , United States/ethnology
10.
Zh Mikrobiol Epidemiol Immunobiol ; (11): 56-61, 1988 Nov.
Article in Russian | MEDLINE | ID: mdl-3064514

ABSTRACT

One of the factors facilitating the global pandemic of Grigor'ev-Shiga dysentery is considered in detail. All Shigella dysenteriae 1 strains, irrespective of the geographical zone of their spread, showed medicinal resistance. As pandemic developed, the spectrum of medicinal resistance constantly increased in all hyperendemic foci. The presence of pronounced relationships between the strains circulating in each of three hyperendemic foci and the strains circulating in different hyperendemic foci could be observed. The necessity of paying greater attention to this dangerous infectious disease, and especially to the problems related to the medicinal resistance of its causative agents, is emphasized.


Subject(s)
Disease Outbreaks/history , Dysentery, Bacillary/history , Global Health , Shigella dysenteriae/drug effects , Africa, Central , Asia, Southeastern , Central America , Disease Reservoirs , Drug Resistance, Microbial/genetics , Dysentery, Bacillary/epidemiology , Dysentery, Bacillary/microbiology , Feces/microbiology , History, 20th Century , Humans , Shigella dysenteriae/genetics , Shigella dysenteriae/isolation & purification
12.
J Hyg (Lond) ; 94(2): 163-72, 1985 Apr.
Article in English | MEDLINE | ID: mdl-3886782

ABSTRACT

A widespread epidemic of severe dysentery in Zaire and neighbouring Central African countries was caused by a multiply drug-resistant strain of Shigella dysenteriae 1. Early isolations were resistant to ampicillin, chloramphenicol, streptomycin, sulphonamides and tetracyclines (R-type = ACSSuT). Later in the epidemic strains resistant to trimethoprim (Tm) became prevalent and a few strains resistant to kanamycin (K) or nalidixic acid were also isolated. All resistances except nalidixic acid were encoded by plasmids of incompatibility groups X (ACT) or I1 (ACSSuTTm) and the epidemic strain also carried an SSu plasmid and a number of cryptic plasmids. The Inc X plasmid from this epidemic is the same as that in Sh. dysenteriae 1 strains isolated in Somalia in 1976 whereas the epidemic strains from the Shiga outbreaks in Central America, 1969 to 1971, and Sri Lanka, 1979, carried plasmids of group B. This epidemic demonstrates that when a multiresistant strain includes resistance to trimethoprim, nalidixic acid is a suitable alternative therapeutic agent.


Subject(s)
Anti-Bacterial Agents/pharmacology , Dysentery, Bacillary/microbiology , R Factors , Shigella dysenteriae/drug effects , Africa, Central , Central America , Chloramphenicol/pharmacology , Democratic Republic of the Congo , Disease Outbreaks , Dysentery, Bacillary/epidemiology , Humans , Kanamycin/pharmacology , Molecular Weight , Nalidixic Acid/pharmacology , Shigella dysenteriae/genetics , Somalia , Trimethoprim/pharmacology
13.
Antimicrob Agents Chemother ; 11(3): 553-8, 1977 Mar.
Article in English | MEDLINE | ID: mdl-324394

ABSTRACT

Ampicillin-resistant strains of Shigella dysenteriae type 1 isolated in epidemics in Mexico, Central America, and Bangla Desh were examined for the presence of plasmid deoxyribonucleic acid (DNA) by gel electrophoresis. All strains contained a heterogeneous population of plasmids. Transfer experiments to Escherichia coli K-12 indicated that the ampicillin resistance determinant (Ap(r)) was located on a 5.5-megadalton (Mdal) plasmid identical in all Shiga strains examined, as judged by DNA hybridization and by its molecular properties. This 5.5-Mdal plasmid contained the ampicillin transposon (TnA) sequences. There was not a high degree of homology between the Shiga Ap(r) plasmid DNA and DNA obtained from Ap(r)Salmonella typhi strains isolated from typhoid epidemics in Mexico, previous to the dysentery outbreaks. Although low, the degree of reassociation observed indicated that probably part of the TnA sequence was present in S. typhi DNA. The DNA hybridization experiments showed, in addition, that there was a high degree of homology among Ap(r) plasmids isolated from different enterobacteria, and this identity was confirmed by restriction endonuclease activity. These results together with their similarities in molecular and replicative properties indicate that the Ap(r) plasmids, as was suggested for the Sm(r) Su(r) plasmids, possibly evolved once and then epidemiologically spread in the Enterobacteriaceae.


Subject(s)
Ampicillin/pharmacology , Dysentery, Bacillary/microbiology , Penicillin Resistance , R Factors , Shigella dysenteriae/drug effects , Bangladesh , Base Sequence , Conjugation, Genetic , Costa Rica , DNA, Bacterial/analysis , Humans , Mexico , Nucleic Acid Hybridization , Shigella dysenteriae/analysis , Shigella dysenteriae/isolation & purification
14.
J Infect Dis ; 133(5): 572-5, 1976 May.
Article in English | MEDLINE | ID: mdl-772132

ABSTRACT

In June 1972, an epidemic of dysentery began in a hospital ward lodging 22 children with tuberculosis. Fifteen of them developed the disease and five children died. The age of the children ranged from five months to four years. A rectal swab culture taken from all hospitalized children three weeks after the initiation of the outbreak revealed Shigella dysenteriae type 1 in five of the patients (28%). The strains isolated were susceptible to cephalothin, gentamicin, kanamycin, colistin, trimethoprim, and nalidixic acid, but were resistant to ampicillin (greater than 5,000 mug/ml), chloramphenicol (300 mug/ml), streptomycin (400 mug/ml), tetracycline (100 mug/ml), and sulfadiazine (1,000 mug per disk). Transfer experiments to Escherichia coli K-12 indicated that these strains were infected with two different plasmids; one was responsible for resistance to chloramphenicol, tetracycline, streptomycin, and sulfonamides, and the other caused resistance to ampicillin. The epidemiological and clinical importance of these findings is emphasized.


Subject(s)
Ampicillin/pharmacology , Dysentery, Bacillary/microbiology , Shigella dysenteriae/drug effects , Child, Preschool , Chloramphenicol/pharmacology , Cross Infection/microbiology , Disease Outbreaks , Humans , Infant , Mexico , Penicillin Resistance , Shigella dysenteriae/isolation & purification , Streptomycin/pharmacology , Sulfonamides/pharmacology , Tetracyclines/pharmacology
16.
Antimicrob Agents Chemother ; 5(3): 310-7, 1974 Mar.
Article in English | MEDLINE | ID: mdl-4599123

ABSTRACT

All 17 Salmonella typhi strains tested from the epidemic in Mexico carried R factors of compatibility group H, conferring resistance to chloramphenicol, streptomycin, tetracycline, and sulfonamides. Some S. typhi strains carried, in addition, non-conjugative, ampicillin resistance plasmids and R factors of the I or A-C complex. All 20 Shigella dysenteriae 1 strains tested of epidemic origin carried O-group R factors. Ampicillin resistance in S. dysenteriae 1 was not proved to be plasmid borne. R factors of group H were not identified in any of the tested Mexican isolates other than S. typhi, but R factors of group O were identified in Escherichia coli, Shigella flexneri, and one strain of S. typhi, as well as in the epidemic S. dysenteriae. An R factor was identified which seemed to have two compatibility specificities, groups Iomega and O.


Subject(s)
Drug Resistance, Microbial , Extrachromosomal Inheritance , Salmonella/drug effects , Shigella dysenteriae/drug effects , Disease Outbreaks , Dysentery, Bacillary/epidemiology , Dysentery, Bacillary/microbiology , Escherichia coli/drug effects , India , Mexico , South Africa , Typhoid Fever/epidemiology , Typhoid Fever/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL